SecBot SecBot
Insider Cluster (7 insiders) ·Filed Jun 1, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago
Insider cluster: 7 insiders, $0.7M total
Actionable Insight • Neutral

The CEO's sales are mechanically tied to option exercises and follow a pattern seen in prior periods, not a fresh bearish signal. The dollar amount is trivial relative to market cap. No actionable trading signal from this cluster alone. Monitor the next 10-Q for any fundamental deterioration that would justify a more cautious stance.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$70.15
T+0 close · Jun 1, 2026 · via day close
Latest settled
+113.91%
T+60 · $150.06
Vs SPY
+112.80%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 2 $70.15entry
  2. T+1 · 6mo ago +3.11%α +3.80% · $72.33
  3. T+5 · 5mo ago −0.13%α +2.84% · $70.06
  4. T+20 · 5mo ago +45.76%α +47.32% · $102.25
  5. T+60 · 3mo ago +113.91%α +112.80% · $150.06
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A cluster of insider selling at Twist Bioscience over the past week, led by CEO Emily Leproust who sold ~$3.2M in open-market shares alongside option exercises, while the CAO and a director also sold smaller amounts. The total open-market sales of ~$4.0M represent ~0.1% of the $4.2B market cap, falling at the low end of the proportionality band. The CEO's sales are part of a regular pattern tied to option exercises, reducing their informational signal per the academic literature.

Key Financial Metrics

Direction
selling
Total Value
$4.0M
Insiders
7

Key Facts

  • CEO Emily Leproust sold 49,516 shares open-market for ~$3.2M across May 26-28, all tied to same-day option exercises at $8.82 or $0 strike
  • CAO Robert Werner sold 800 shares for ~$50K on May 26
  • Director Melissa Starovasnik sold 3,000 shares for ~$201K across May 26 and May 28
  • Total open-market sales in the cluster: ~$4.0M, or ~0.1% of market cap
  • Non-cash option exercises (M transactions) by CEO totaled $0 economic value for 65,769 shares
  • Prior 30-day insider activity showed 5 sells totaling $3.4M, consistent with ongoing selling pattern

Financial Impact

Total open-market sales of ~$4.0M, representing ~0.1% of $4.2B market cap

dilutioninsider ownership

Risk Factors

  • CEO selling alongside option exercises could be misinterpreted as bearish by the market
  • If the company reports disappointing earnings in the next quarter, the insider sales may be viewed in hindsight as informed

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TWST-1780344427670

US Market Status

Market Closed · Opens Wed (13h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 1, 2026